Innovation Theater 3
Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.

---

Program Description

Please join expert pulmonologist Steven Nathan, MD and expert radiologist Jonathan Chung, MD as they team up to highlight the role of collaborative care in the diagnosis and management of patients with interstitial lung disease (ILD). Attendees will have the opportunity to test their knowledge in real time through an interactive presentation of sample patient cases. Attendees will be quizzed on the key signs and symptoms for early and accurate diagnoses, demonstrate the importance of HRCT (high-resolution computed tomography) imaging, and address challenges in caring for this patient population.

An Industry Program presentation at the ATS 2024 International Conference.

This presentation is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and is open to all ATS 2025 International Conference attendees.

This is a non-CME event and does not qualify for CME or CE credit. Onsite registration/admission will occur for conference registrants only at the industry theater entrance, on a first-come, first-serve basis.

Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing medical education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted. (03/25) EM-US-103750

Speakers

Presenter: Steven Nathan, MD
Inova Fairfax Hospital
Advanced Lung Disease & Transplant Program
Medical Director
Falls Church, Virginia

Presenter: Jonathan H. Chung, MD
University of California
Cardiothoracic Imaging
Division Chief
San Diego, California